ATE65397T1 - Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol. - Google Patents

Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.

Info

Publication number
ATE65397T1
ATE65397T1 AT88202492T AT88202492T ATE65397T1 AT E65397 T1 ATE65397 T1 AT E65397T1 AT 88202492 T AT88202492 T AT 88202492T AT 88202492 T AT88202492 T AT 88202492T AT E65397 T1 ATE65397 T1 AT E65397T1
Authority
AT
Austria
Prior art keywords
acid
oligomers
butanediol
esters
derivative
Prior art date
Application number
AT88202492T
Other languages
English (en)
Inventor
William Nichels
Oultremont Philippe D
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Application granted granted Critical
Publication of ATE65397T1 publication Critical patent/ATE65397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88202492T 1987-11-19 1988-11-08 Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol. ATE65397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE8701314A BE1001209A3 (fr) 1987-11-19 1987-11-19 Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
EP88202492A EP0316993B1 (de) 1987-11-19 1988-11-08 Pharmazeutische Zusammensetzungen mit Gehalt an einem Derivat der 3-Hydroxy-Buttersäure, ausgewählt aus den Oligomeren dieser Säure und den Estern dieser Säure oder dieser Oligomere mit dem 1,3-Butan-diol

Publications (1)

Publication Number Publication Date
ATE65397T1 true ATE65397T1 (de) 1991-08-15

Family

ID=3882973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88202492T ATE65397T1 (de) 1987-11-19 1988-11-08 Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.

Country Status (10)

Country Link
US (1) US5112865A (de)
EP (1) EP0316993B1 (de)
JP (1) JPH01160917A (de)
AT (1) ATE65397T1 (de)
BE (1) BE1001209A3 (de)
CA (1) CA1330307C (de)
DE (1) DE3863904D1 (de)
DK (1) DK168269B1 (de)
ES (1) ES2037818T3 (de)
GR (1) GR3002605T3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) * 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
AU6513298A (en) * 1997-03-17 1998-10-12 British Technology Group Limited Therapeutic compositions
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6164451A (en) * 1998-03-16 2000-12-26 Trish Mcevoy, Ltd. Cosmetics case
DE19830310A1 (de) * 1998-07-07 2000-01-13 Riedel De Haen Gmbh Verfahren zur Abreicherung des Bromidgehaltes aus einer wäßrigen Bromid enthaltenden Lösung unter Verwendung von Wasserstoffperoxid
CA2338090C (en) 1998-07-22 2009-07-14 Metabolix, Inc. Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies
US20020077269A1 (en) * 2000-10-27 2002-06-20 Whitehouse Robert S. Alkanoic acid ester monomer compositions and methods of making same
AU2002357355A1 (en) 2001-12-18 2003-06-30 Metabolix, Inc. Methods of making intermediates from polyhydroxyalkanoates
AU2004245567B2 (en) * 2003-06-03 2011-06-23 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives
GB0410266D0 (en) * 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
ES2730879T3 (es) 2008-01-04 2019-11-13 Univ Oxford Innovation Ltd Cuerpos de cetona y ésteres de cuerpos de cetona como agentes reductores de lípidos de la sangre
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
ES2655367T3 (es) * 2008-08-21 2018-02-19 Oxford University Innovation Limited Bebida que comprende éster de hidroxibutirato y uso médico de la misma
CN102781901B (zh) 2010-02-11 2016-08-03 梅塔玻利克斯公司 用于从经遗传修饰的聚羟基链烷酸酯生物质制备单体组分的方法
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
AU2013337308B2 (en) 2012-11-05 2018-06-21 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
CN105246870A (zh) 2013-03-14 2016-01-13 伊希斯创新有限公司 (r)-3-羟基丁酸(r)-3-羟基丁酯的制备方法
WO2017213999A1 (en) 2016-06-07 2017-12-14 The J. David Gladstone Institutes Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
IL272173B2 (en) * 2017-07-21 2025-06-01 Buck Inst Res Aging S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
WO2019147503A1 (en) 2018-01-25 2019-08-01 Buck Institute For Research On Aging Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds
WO2021195477A1 (en) 2020-03-27 2021-09-30 Ketoneaid, Inc. Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500310C2 (de) * 1975-01-07 1984-01-19 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Butandiol-(1,3)-1-mono-(3'-hydroxybutyraten)sowie einige dieser Butandiol-(1,3)-1-mono-(3'-hydroxybutyrate)
DE2500312C2 (de) * 1975-01-07 1984-01-19 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Butandiol-(1,3)-3-mono-(3'-hydroxybutyraten)sowie einige dieser Butandiol-(1,3)-3-mono-(3'-hydroxybutyrate)
FR2486072A1 (fr) * 1980-07-03 1982-01-08 Solvay Procede pour la fabrication de l'acide b-hydroxybutyrique et de ses oligocondensats
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
US5100677A (en) * 1985-12-18 1992-03-31 Veech Richard L Fluid therapy with various organic anions

Also Published As

Publication number Publication date
DK168269B1 (da) 1994-03-07
US5112865A (en) 1992-05-12
EP0316993B1 (de) 1991-07-24
GR3002605T3 (en) 1993-01-25
BE1001209A3 (fr) 1989-08-22
JPH01160917A (ja) 1989-06-23
DK644388A (da) 1989-07-03
EP0316993A1 (de) 1989-05-24
ES2037818T3 (es) 1993-07-01
DE3863904D1 (de) 1991-08-29
CA1330307C (fr) 1994-06-21
DK644388D0 (da) 1988-11-18

Similar Documents

Publication Publication Date Title
ATE65397T1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
DK375588A (da) Methylenphosphonalkylphosphinsyreforbindelser og farmaceutiske sammensaetninger indeholdende samme
DE69329070D1 (de) Verfahren zur Reinigung von Beta-Carotin
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
DK385488D0 (da) Farmaceutisk praeparat indeholdende somatostatinanaloge
FI914409A0 (fi) Kalciumupptagande inhibitorer.
ATE45091T1 (de) Pharmazeutische zubereitung mit speziellen 1,2diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE59409275D1 (de) Tabletten mit Thioctsäure bestimmter Korngrösse
FI942275L (fi) 1,3,5-triatsin-2,4,6-tris-alkyyliaminokarboksyylihappoaminoesterit, näitä sisältävät biosidiset aineet sekä menetelmät niiden valmistamiseksi
NZ231320A (en) Aqueous oral preparations of diclofenac
ATE130289T1 (de) 1,3-diphenyl-2-propin-1-one.
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
DK576887D0 (da) Farmaceutiske midler
FR2673639B1 (fr) Fractions enrichies en acide gras extraites de morinda et compositions insecticides contenant lesdites fractions et/ou des acides gras.
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
IT8219650A0 (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
MX9201482A (es) Acidos carboxilicos opticamente activos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IT8323161A0 (it) Procedimento di preparazione di acidi monocarbossilici bisostituiti in beta da idrocarburi aciclici o ciclici.
IT8705109A0 (it) Impianto per il trattamento diprodotti derivati da matrici idrocarburiche per separarne delle frazioni riutilizzabili.
MX9203260A (es) Derivados anillados del acido tetrahidropiridinacetico y composiciones farmaceuticas que los contienen.
IT8067126A0 (it) Sulfossimmidi sostituite particolarmente utili come spasmolitici e broncolitici e prodotti farmaceutici contenenti tali composti